Anika Therapeutics
ANIK
ANIK
109 hedge funds and large institutions have $206M invested in Anika Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
-13
Holders Change %
-10.66%
% of All Funds
1.45%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
15
Increased
39
Reduced
39
Closed
27
Calls
$47K
Puts
$31K
Net Calls
+$16K
Net Calls Change
+$16K
Top Buyers
1 |
AFA
Alta Fundamental Advisers
New York
|
+$6.66M |
2 |
![]()
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.96M |
3 |
![]()
JPMorgan Chase & Co
New York
|
+$1.1M |
4 |
UBS Group
Zurich,
Switzerland
|
+$1.01M |
5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$805K |
Top Sellers
1 |
Morgan Stanley
New York
|
-$4.34M |
2 |
BlackRock
New York
|
-$3.4M |
3 |
![]()
Franklin Resources
San Mateo,
California
|
-$3.38M |
4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$2.69M |
5 |
RP
Riverwater Partners
Milwaukee,
Wisconsin
|
-$2.55M |